Galera to Present at 2022 American Society for Radiation Oncology Annual Meeting

Galera Therapeutics

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that tumor outcomes data from its Phase 3 ROMAN trial of avasopasem for severe oral mucositis (SOM) and final data from its Phase 2 AESOP trial of avasopasem for chemoradiotherapy-induced esophagitis will be highlighted in two presentations at the upcoming 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting, taking place October 23-26, 2022 in San Antonio, Texas. Additionally, poster presentations will highlight the Phase 2 EUSOM trial of avasopasem for SOM in Europe and the ongoing GRECO-1 trial of rucosopasem for non-small cell lung cancer.

Presentation Details

Title: Tumor Outcomes for ROMAN: Phase 3 Trial of Avasopasem Manganese (GC4419) for Severe Oral
Mucositis (SOM) in Patients Receiving Chemoradiotherapy (CRT) for Locally Advanced Head and Neck Cancer (LAHNC)
Abstract Number: 280
Presenter: Carryn M. Anderson, M.D., University of Iowa Hospitals & Clinics
Session Title: H&N 3 – Toxicity Mitigation and HPV-Unrelated Head and Neck Cancer – Life Beyond De-Intensification
Session Date and Time: Wednesday, October 26, 2022 | 12:40 p.m. CDT
Session Location: Henry B. Gonzalez Convention Center, Room 214

Title: AESOP: Phase 2 Open-Label Trial of Avasopasem Manganese (GC4419) for Reduction of Esophagitis in Patients Receiving Chemoradiotherapy for Nonmetastatic Lung Cancer
Abstract Number: 1124
Presenter: Bryan G. Allen, M.D., Ph.D., University of Iowa Hospitals & Clinics
Session Title: Lung 3 – Optimizing Radiation Dose, Volume, and Concomitant Systemic Agents
Session Date and Time: Wednesday, October 26, 2022 | 10:50 a.m. CDT
Session Location: Henry B. Gonzalez Convention Center, Room 303

Poster Q&A Details

Title: GRECO-1: Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) with or without Rucosopasem (GC4711) for Early Stage, Peripheral or Centrally Located Non-Small Cell Lung Cancer (NSCLC)
Abstract Number: 2841
Presenter: Puneeth Iyengar, M.D., Ph.D., UT Southwestern Medical Center
Session Title: Poster Q&A 01 – Lung Cancer and DEIH
Session Date and Time: Sunday, October 23, 2022 | 4:45 p.m. CDT
Session Location: Henry B. Gonzalez Convention Center, Exhibit Hall 1

READ:  Zynerba Pharmaceuticals Announces Poster Presentation at the Annual Meeting of the American College of Neuropsychopharmacology

Title: EUSOM: Phase 2 Trial of Avasopasem Manganese (GC4419) for Oral Mucositis in Patients Receiving Chemoradiotherapy for Locally Advanced, Nonmetastatic Head and Neck Cancer
Abstract Number: 2687
Presenter: Jordi Giralt, M.D., Ph.D., Vall d’Hebron University Hospital
Session Title: Poster Q&A 09 – Head & Neck Cancer and Health Services Research
Session Date and Time: Wednesday, October 26, 2022 | 10:30 a.m. CDT
Session Location: Henry B. Gonzalez Convention Center, Exhibit Hall 1

The titles of the abstracts are currently available in the ASTRO digital program, with the full abstracts available on Friday, October 21, 2022, at 5 p.m. CDT.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.